MATE 2 Substrates with a Narrow Therapeutic Index
DBCAT004526Pharmacologic class
A DrugBank category of 4 drugs. 4 of them are approved.
- Part of
- MATE 2 Substrates
What you can answer from here — as of July 05, 2019
Which targets do MATE 2 Substrates with a Narrow Therapeutic Index share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account